ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 4 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.


Player Avatar MotleyViking (98.51) Submitted: 6/18/2014 7:03:55 PM : Outperform Start Price: $35.55 ISIS Score: +38.07

Deep pipeline, seemingly has a lot of promise/potential with several drugs.Could be a takeover target, though I don't think there is a much of a chance for that. Value for ISIS is all about their pipeline so we'll see what happens going forward.

Featured Broker Partners